Neurocrine Biosciences To Present at the First Annual Needham & Company Biotechnology Conference
SAN DIEGO, May 31 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will be presenting at the First Annual Needham & Company Biotechnology Conference held in New York. The webcast will be held Tuesday, June 4, 2002 at 11:00 AM Eastern Daylight Time (EDT)/ 8:00 AM Pacific Daylight Time (PDT). Participants may access this webcast through a link provided via the Company's website at www.neurocrine.com or alternatively at http://www.twst.com/econf/mm/needham2/nbix.
Gary Lyons, President and CEO of Neurocrine Biosciences, will give an update on the Company's insomnia program as well as highlighting the Company's clinical programs. If you are unable to attend the Webcast and would like further information on this announcement please contact Claudia Jones or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com.
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X36870684
SOURCE Neurocrine Biosciences, Inc.
Web site: http: //www.neurocrine.com
CONTACT: Claudia Jones or Elizabeth Foster, of Neurocrine Biosciences, Inc., +1-858-658-7600